efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet

RxCUI
643066
RxNorm name
efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
Display name
efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
Full name
efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Efavirenz, Emtricitabine And Tenofovir Disoproxil FumarateEFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEBryant Ranch Prepackec61f069-632e-4628-b9b1-701d381a1a062025-11-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 643066
Efavirenz, emtricitabine and tenofovir disoproxil fumarateEFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATELaurus Labs Limitedaca22076-f435-4533-9fcf-566b0734c3132025-07-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 643066
Efavirenz, Emtricitabine and Tenofovir Disoproxil FumarateEFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATETeva Pharmaceuticals USA, Inc.fc9c2149-8d40-401b-af13-5ae7f953950a2024-05-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 643066
Efavirenz, Emtricitabine And Tenofovir Disoproxil FumarateEFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEAurobindo Pharma Limited1b71df95-b1ce-4e40-908a-67fb336457f42023-12-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 643066
Efavirenz, Emtricitabine and Tenofovir Disoproxil FumarateEFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATECamber Pharmaceuticals, Inc.5f261872-d705-4549-a43d-2ad6b0164dc32022-07-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 643066
Efavirenz, Emtricitabine and Tenofovir Disoproxil FumarateEFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEMacleods Pharmaceuticals Limited3b244bb3-2e8b-4fde-b69d-330aca56fb8e2021-09-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 643066
efavirenz, emtricitabine and tenofovir disoproxil fumarateEFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATECipla USA Inc.a7d94a1c-31b0-4272-8f8d-186d580e16e02021-03-11Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 643066

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ec61f069-632e-4628-b9b1-701d381a1a06efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletSCD100These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620251104
ec61f069-632e-4628-b9b1-701d381a1a06efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletPSN100These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620251104
ec61f069-632e-4628-b9b1-701d381a1a06efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSY100These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620251104
fc9c2149-8d40-401b-af13-5ae7f953950aefavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletPSN7These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620240528
fc9c2149-8d40-401b-af13-5ae7f953950aefavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletSCD7These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620240528
fc9c2149-8d40-401b-af13-5ae7f953950aefavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSY7These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620240528
1b71df95-b1ce-4e40-908a-67fb336457f4efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletPSN5These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620231228
1b71df95-b1ce-4e40-908a-67fb336457f4efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSY5These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620231228
1b71df95-b1ce-4e40-908a-67fb336457f4efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletSCD5These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620231228
aca22076-f435-4533-9fcf-566b0734c313efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSY3These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620250728
aca22076-f435-4533-9fcf-566b0734c313efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletSCD3These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620250728
aca22076-f435-4533-9fcf-566b0734c313efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletPSN3These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620250728
a7d94a1c-31b0-4272-8f8d-186d580e16e0efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletSCD3These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET. EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620210311
a7d94a1c-31b0-4272-8f8d-186d580e16e0efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletPSN3These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET. EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620210311
a7d94a1c-31b0-4272-8f8d-186d580e16e0efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSY3These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET. EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620210311
076da359-b3d0-44f7-8c0e-662f5b7a8668efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletPSN3These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 200620170123
076da359-b3d0-44f7-8c0e-662f5b7a8668efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSY3These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 200620170123
076da359-b3d0-44f7-8c0e-662f5b7a8668efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletSCD3These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 200620170123
2096a07e-8601-4bdc-ba5a-338a40cd02e9efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletPSN3These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 200620130503
2096a07e-8601-4bdc-ba5a-338a40cd02e9efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletSCD3These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 200620130503
2096a07e-8601-4bdc-ba5a-338a40cd02e9efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSY3These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 200620130503
5f261872-d705-4549-a43d-2ad6b0164dc3efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSY1These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620220728
5f261872-d705-4549-a43d-2ad6b0164dc3efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletPSN1These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620220728
5f261872-d705-4549-a43d-2ad6b0164dc3efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletSCD1These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620220728
3b244bb3-2e8b-4fde-b69d-330aca56fb8eefavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletPSN1These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620210918
3b244bb3-2e8b-4fde-b69d-330aca56fb8eefavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSY1These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620210918
3b244bb3-2e8b-4fde-b69d-330aca56fb8eefavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletSCD1These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620210918
1e81fa46-1164-4a34-b212-dcc16f3dc2c6efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSY1These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET. EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620210312
1e81fa46-1164-4a34-b212-dcc16f3dc2c6efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletPSN1These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET. EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620210312
1e81fa46-1164-4a34-b212-dcc16f3dc2c6efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletSCD1These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET. EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 200620210312